Journal of Biological Chemistry · 1999 · 124 citations · 30 references
Life SciencesBiochemistryMolecular BiologyEnzymologyProtein BiochemistryProtein-protein InteractionsEnzyme FunctionEnzyme InhibitionProtein DomainsProtein StructureProteolytic EnzymesStructural DomainsAspartic ProteasesCathepsin ActivityCysteine ProteasesLimited ProteolysisProtease InhibitionProtease InhibitorsProteolytic ActivityProteolytic Enzyme Activity
Equistatin from sea anemone is a protein composed of three thyroglobulin-type 1 domains known to inhibit papain-like cysteine proteinases, papain, and cathepsins B and L. Limited proteolysis was used to dissect equistatin into a first domain, eq d-1, and a combined second and third domain, eq d-2,3. Only the N-terminal domain inhibits papain (Ki = 0.61 nM). Remarkably, equistatin also strongly inhibits cathepsin D with Ki = 0.3 nM but not other aspartic proteinases such as pepsin, chymosin, and HIV-PR. This activity resides on the eq d-2,3 domains (Ki = 0.4 nM). Papain and cathepsin D can be bound and inhibited simultaneously by equistatin at pH 4.5, confirming the physical separation of the two binding sites. Equistatin is the first inhibitor of animal origin known to inhibit cathepsin D. The obtained results demonstrate that the widely distributed thyroglobulin type-1 domains can support a variety of functions.
30
How to measure and predict the molar absorption coefficient of a protein
C. Nick Pace, F.F. Vajdos, Lanette Fee et al. · Protein Science · 1995 · 3.9K citations · Full text
A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases
Ryōsuke Takahashi, Quinn L. Deveraux, Ingo Tamm et al. · Journal of Biological Chemistry · 1998 · 608 citations · Full text